NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
USDÂ 66,34
arrow_upward
+1,86%(+1,21) 1D
13 Okt., 14:15:56 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMY...
Open
USDÂ 66,53
High
USDÂ 66,62
Low
USDÂ 65,83
Mkt. cap
180,58Â mjd
Avg. vol.
23,92Â k
Volume
18,16Â k
52-wk high
USDÂ 75,26
52-wk low
USDÂ 49,90
Beta
0,87
Shares outstanding
414,56Â m
No. of employees
11Â k
Open
USDÂ 66,53
High
USDÂ 66,62
Low
USDÂ 65,83
Mkt. cap
180,58Â mjd
Avg. vol.
23,92Â k
Volume
18,16Â k
52-wk high
USDÂ 75,26
52-wk low
USDÂ 49,90
Beta
0,87
Shares outstanding
414,56Â m
No. of employees
11Â k
News stories
From web sources and news partners
StreetInsider
·
1 dag gelede
Transactions under Novonesis’ share buyback program
Simply Wall Street
·
1 dag gelede
Novozymes (CPSE:NSIS B) Expands Wisconsin Capacity, Is The Stock Still 12% Undervalued?
Profile
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
CEOEster Baiget
Employees11,1Â k
Founded2000
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com